Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxaliplatin and Gemcitabine in Malignant Pleural or Peritoneal Mesothelioma
NCT00859469Phase 2Completed
- Sponsor
- Columbia University
- Start
- Apr 2004
- Primary completion
- Mar 2009
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin, gemcitabine in mesothelioma, sponsored by Columbia University. Started Apr 2004; status: completed.
02
Drugs
oxaliplatingemcitabine
03
Conditions
mesothelioma
Beyond the preview
Go deeper on NCT00859469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00859469.